Nuvalent, Inc. (NUVL)
NASDAQ·Healthcare·Biotechnology
$123.25
-0.16%
Mkt Cap $9.07B
Analyst Ratings
Buy
5
Hold
9
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
Implied Upside
+11.5%
Consensus $137.44 vs current $123.25
NASDAQ·Healthcare·Biotechnology
$123.25
-0.16%
Mkt Cap $9.07B
Buy
5
Hold
9
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
+11.5%
Consensus $137.44 vs current $123.25